Glaxo Bipolar Drug May Be Tied to Defect
Philadelphia Enquirer - WASHINGTON - Federal health officials cautioned women Friday that use of a GlaxoSmithKline drug during the first three months of pregnancy shows possible links to birth defects. Newly reported data suggest a connection between the drug Lamictal, used …